Nvest Wealth Strategies’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
JEST
MIP
EIC
MHI
DLA
Nvest Wealth Strategies's GSK Position: Q2 2026 in Review
Nvest Wealth Strategies reduced its GSK (GSK) stake by 11% in Q2 2026, selling an estimated $317 and leaving 48 shares worth $2.52K. The position accounts for ﹤0.01% of the portfolio, ranked #181.
Nvest Wealth Strategies first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.98K in Q1 2026. 627 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Nvest Wealth Strategies held 48 shares of GSK worth $2.52K as of Q2 2026.
- Nvest Wealth Strategies sold 6 GSK shares in Q2 2026, an estimated $317.
- GSK made up ﹤0.01% of Nvest Wealth Strategies's portfolio in Q2 2026, its #181 holding.
- Nvest Wealth Strategies first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
- Nvest Wealth Strategies's GSK position peaked at $2.98K in Q1 2026.
- 627 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Nvest Wealth Strategies's 13F filing for Q2 2026, filed 10 Jul 2026.